Biolevate's raises €6M to helps medical writers keep up with the pace of new drugs | TechCrunch

Biolevate raises €6M to help medical writers keep up with the pace of new drugs using NLP and computer vision to assist in the writing process.

– Biolevate's Drug Development Platform

Biolevate was founded by two long-time friends, Joel Belafa and Nathan Chen, who have expertise in AI and pharmaceutical processes respectively.

- Founders' Expertise

Download App

The biotech industry faces a significant administrative burden in creating documentation to satisfy regulators, which Biolevate aims to streamline.

- Addressing Documentation Burden

Download App

Biolevate's platform uses NLP and Computer Vision to guide medical writers, reducing the time and effort needed to understand or correct the system.

- Platform Capabilities

Download App